Trial Profile

A Phase IV, Real World, Open-label, Multi-centre Study on the Use of FOQUEST (Methylphenidate Hydrochloride Controlled-release Capsules) for the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Pediatric and Adult Patients

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 20 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

14 Sep 2021 Status changed from active, no longer recruiting to completed.
19 May 2021 Planned End Date changed from 1 Aug 2020 to 1 Jul 2021.
19 May 2021 Planned primary completion date changed from 1 Aug 2020 to 1 Jul 2021.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com